openPR Logo
Press release

What's driving The Gynaecological cancer drugs market Growth? Top Players - AstraZeneca, Sanofi, Pfizer, Takeda Pharmaceuticals Co. Ltd., Bristol-Myers Squibb, Merck & Co., Dr Reddy’s Laboratories, Johnson & Johnson (Alza Corporation), and GlaxoSmithKli

What's driving The Gynaecological cancer drugs market Growth?

According to the American Cancer Society, ovarian cancer ranks fifth resulting in death among women, accounting for a maximum number of deaths compared to any other cancer of female reproductive system. However, over the past 20 years, the number of women diagnosed with ovarian cancer is decreasing. This is due to the discovery of new drugs and treatments for treating gynaecological cancer. Increasing number of drugs have been approved by Food and Drugs Administration (FDA) for gynaecological cancer. Meanwhile, a lot of drugs developed by pharmaceutical firms are under clinical trials. Generic drugs are also gaining traction in the gynaecological cancer drugs market. Meanwhile, personalized medicine approach and targeted therapies also present an opportunity for companies operating in the global gynaecological cancer drugs market.

The global gynaecological cancer drugs market is segmented into distribution channels, indication, end users, drug class, and region. Based on the drug class, the market is divided into antitumor antibiotic, anthracyclines, plant alkaloid, alkylating agent, and other drug class. Antitumor antibiotic is expected to grow at a faster phase any other drug class. By the end of 2026, antitumor antibiotic is estimated to bring in more than US$ 13,700 million revenue.

Get Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/21700

The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026.
Treatment of cancer is being increasingly focused on be leading pharmaceutical companies, researchers, healthcare institutes and governments of various countries. With increasing number of research and development activities in cancer treatment, especially in gynaecological cancer treatment, new treatments are reaching an increasing number of physicians faster than ever. Also, availability of advanced treatment options and drugs has resulted in the decline in cancer mortality rate across major developed countries. However, the scenario is not same in the developing nations. This is due to the high cost of cancer treatment and lack of availability of new treatments.

Roche Holdings AG, AstraZeneca, Sanofi, Eli Lilly & Co., Pfizer Inc., Takeda Pharmaceuticals Co. Ltd., Bristol-Myers Squibb, Merck & Co., Dr Reddy’s Laboratories, Johnson & Johnson (Alza Corporation), and GlaxoSmithKline (GSK), are some of the leading companies operating in the global gynaecological cancer drugs market.

By end users, the market segmentation includes specialized cancer treatment centers, clinics, hospitals and others. Among these, hospitals are expected to be the largest users of gynaecological cancer drugs. Hospitals are estimated to exceed US$ 16,300 million revenue towards the end of 2026.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/21700

Based on the indication, the market is further segmented into vaginal cancer, vulvar cancer, ovarian & fallopian tube cancer, uterine cancer, and cervical cancer. Uterine cancer is expected to account for the highest revenue share. By the end of 2026, uterine cancer is estimated to exceed US$ 22,500 million revenue.
By distribution channel, the market is divided into e-commerce, retail pharmacies, and hospital pharmacies. Among these, hospital pharmacies are expected to witness the highest growth during the forecast period. Hospital pharmacies are estimated to bring in more than US$ 15,000 million revenue by the end of the forecast period.

North America is expected to be one of the leading regions in the global gynaecological cancer drugs market. Well-developed healthcare infrastructure, presence of the major pharmaceutical companies, increasing investment in the research and development of new drugs and therapies to treat gynaecological cancer are some of the factors contributing to the growth of the market in the region.

3. Global Gynaecological Cancer Drugs Market Overview
3.1. Introduction
3.1.1. Global Gynaecological Cancer Drugs Market Taxonomy
3.1.2. Global Gynaecological Cancer Drugs Market Definition
3.2. Global Gynaecological Cancer Drugs Market Size (US$ Mn) and Forecast, 2012-2026

3.2.1. Global Gynaecological Cancer Drugs Market Y-o-Y Growth
3.3. Global Gynaecological Cancer Drugs Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Cancer service provision by level of healthcare
3.7. Gynaecological cancer drugs in pipeline

3.8. Use of Nanomedicine for the treatment of Gynaecological Cancers
3.9. Gynaecological Cancer Epidemiology
3.10. Patent Analysis
3.11. PESTL Analysis
3.12. Product Lifecycle
3.13. Service Provider List
3.14. Key Participants Market Presence (Intensity Map) By Region

4. Global Gynaecological Cancer Drugs Market Analysis and Forecast 2012-2026
4.1. Global Gynaecological Cancer Drugs Market Size and Forecast By Drug Class, 2012-2026
4.1.1. Alkylating Agent Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region

4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Plant Alkaloid Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Anthracyclines Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region

4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Antitumor Antibiotic Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region

4.1.5. Other Drug Class Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.2. Global Gynaecological Cancer Drugs Market Size and Forecast By End User, 2012-2026
4.2.1. Hospitals Market Size and Forecast, 2012-2026

4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Clinics Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region

4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Other End Users Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region

4.2.4.3. Y-o-Y growth Comparison, By Region
4.3. Global Gynaecological Cancer Drugs Market Size and Forecast By Indication, 2012-2026
4.3.1. Cervical Cancer Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region

4.3.2. Uterine Cancer Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Ovarian & Fallopian Tube Cancer Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region

4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Vulvar Cancer Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
4.3.5. Vaginal Cancer Market Size and Forecast, 2012-2026
4.3.5.1. Revenue (US$ Mn) Comparison, By Region

4.3.5.2. Market Share Comparison, By Region
4.3.5.3. Y-o-Y growth Comparison, By Region
4.4. Global Gynaecological Cancer Drugs Market Size and Forecast By Distribution Channel, 2012-2026
4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region

4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
4.4.3. Market Size and Forecast, 2012-2026
4.4.3.1. Revenue (US$ Mn) Comparison, By Region
4.4.3.2. Market Share Comparison, By Region
4.4.3.3. Y-o-Y growth Comparison, By Region

5. North America Gynaecological Cancer Drugs Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026

5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Drug Class
5.6. Revenue (US$ Mn) Comparison, By End User
5.7. Revenue (US$ Mn) Comparison, By Indication
5.8. Revenue (US$ Mn) Comparison, By Distribution Channel

Full Report@ https://www.persistencemarketresearch.com/market-research/gynaecological-cancer-drugs-market.asp

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving The Gynaecological cancer drugs market Growth? Top Players - AstraZeneca, Sanofi, Pfizer, Takeda Pharmaceuticals Co. Ltd., Bristol-Myers Squibb, Merck & Co., Dr Reddy’s Laboratories, Johnson & Johnson (Alza Corporation), and GlaxoSmithKli here

News-ID: 1790558 • Views:

More Releases from persistencemarketresearch.com

Innovation-Based Discernment To Drive The Foil Shavers Market
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Growth According to 'Persistence Market Research'
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are Haw Par Corporation Limited., Procter & Gamble, GSK group of companies, Amrutanjan Health Care Ltd. and others. The companies are mainly focusing on intense marketing to conve
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia

All 5 Releases


More Releases for Comparison

FX-Toprebates.com - Trusted Broker Cashback Comparison
Altenglan - Forex trading is considered one of the best ways for average investors to make a decent and substantial profit even from small investments and a short period of time. Expansion of Forex trading in the market through new investors has significantly driven numerous established brokers to introduce certain programs that will encourage investors to make use of their services. Some of the common incentives involved are cashback and
Acephate Market - Strategies, Comparison, Shares 2023
Acephate is an organophosphate foliar insecticide sold as a soluble powder, as emulsifiable concentrates, as pressurized aerosol, and in tree injection systems and granular formulations. It is basically an insecticide made of esters of phosphoric acid. It is used primarily for control of aphids, including resistant species, in vegetables such as carrots, potatoes, tomatoes and lettuce. Acephate is an organophosphate insecticide. It is used on food crops, citrus trees, as
Moneybrag.com Offers Reliable Financial Comparison Services
Moneybrag.com is a leading online firm that specializes in online comparison services that enable clients to make comparisons of utility and personal finance products. Their primary goal is to provide information in an understandable format that allows for initial comparisons to be made at a glance. This enables customers to make healthy financial decisions. Moneybrag.com gives customers the ability to compare side by side and select a vendor based on
Comparison of Time recording applications
With hiring remote staff and freelancers halfway around the world turning into further common, it is necessary to look out the only thanks to keep track of the hours they work. Not entirely are you able to would like to know the hours to be able to pay them at the tip of the month but together notice an easy due to manage the invoices of an entire team. If
EInsuranceEz.com Launches Health Insurance Comparison Portal
EInsuranceEz.com, the online insurance price comparison company, launched a brand new customer-focused website this month. The site, einsuranceez.com, is designed to offer customers a wide range of competitively-priced life insurance, health insurance and auto insurance quotes instantly online. Working with some of the US biggest providers, EInsuranceEz.com constantly compares the best deals and insurance rates on the market to ensure that the customer gets the greatest saving for them. The company VP
PriceForSure.com - Benefits of Comparison Shopping
Comparison Shopping websites are beneficial to consumers and merchants because they offer a number of benefits. ( EMAILWIRE.COM, June 20, 2007 ) Rincon, Georgia – PriceForSure.com (www.PriceForSure.com) announces the benefits of comparison shopping. This informative and often entertaining form of shopping makes it easier for consumers to find the best deals on the web. Consumers search for products that they are interested in by comparing product types, product features,